Category Archives: Recalled Drugs

Featured Stories

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that the risk of atypical thigh fractures increases the longer a ...

Read More

EMA Seeks Stronger Pradaxa Guidance for Bleeding Side Effects

Regulators in Europe have again asked Boehringer Ingelheim, the manufacturer of the blood thinner Pradaxa, to update the drug’s label with additional information regarding Pradaxa bleeding side effects. According to the European Medicines Agency (EMA), the new guidance should include more specific information on when Pradaxa must not be used, ...

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed.

Read More

Dozens Receive Nonsterile Simulated Saline Solution

Dozens-Receive-Nonsterile-Simulated-Saline-Solution

The FDA said last week that more than 40 patients had received intravenous simulated saline that was not sterile and was not intended for human use.

Read More

Fracking Should be Kept 600m From Aquifers, Study Says

New research on the safety of hydraulic fracturing (fracking) suggests new wells should not be dug within 600 meters of a water aquifer because underground fractures can extend about that far from a dug well. According to a report from UK’s The Guardian newspaper, researchers and geologists at Durham University have ...

Read More

Retailers Accused of Selling Fraudulent Herbal Supplements

Major Retailers Accused of Selling Fraudulent Herbal Supplements

The NYS attorney general’s office has accused four national retailers of selling fraudulent dietary supplements.

Read More

Cancer Groups Call for E-cigarettes Regulation/Research

Two Leading Cancer Groups Issue Call for Regulation of E-cigarettes and Research on Health Risks

In a joint statement, the American Society of Clinical Oncology and the American Association for Cancer Research have called on the federal government to move quickly to regulate e-cigarettes and increase research on their health effects. These leading research and treatment organizations asked the Food and Drug Administration (FDA) to make ...

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Western Pennsylvania Familes File Suit Over Alleged Fracking Pollution

Three families in western Pennsylvania believe a leading hydraulic fracturing (fracking) company and two water testing labs are conspiring to produce false results that show natural gas drilling is not contaminating their private water wells.

Read More

System for Tracking Prescription Drug Side Effects Flawed

Study Finds System for Tracking Prescription Drug Side Effects Flawed

System for keeping track of dangerous side effects of prescription drugs is flawed because drug makers are submitting incomplete information about problems to the FDA.

Read More

Class III Voluntary Recall Issued for High Blood Pressure Medication

Class III Recall Issued for High Blood Pressure Medication

As a result of a recent Enforcement Report of the U.S. Food and Drug Administration (FDA), Sun Pharma and Lupin  are recalling over 41.5 thousand drug bottles in the United States. Sun Pharmaceutical Industries Inc. is recalling 12,109 bottles of … Continue reading

Posted in Pharmaceuticals, Product Recalls, Recalled Drugs | Tagged , , , , , , |

Teva Pharmaceuticals Initiates Voluntary Recall due to Potential Glass Particulate Matter

Teva Pharmaceuticals Initiates Voluntary Recall due to Glass

Teva Pharmaceuticals based in North Wales, Pennsylvania, announced a voluntary recall of seven lots of Amikacin Sulfate Injection USP, 500 mg/2mL and 1 tram/4mL vials as a result of the potential presence of glass particulate matter. Amikacin Sulfate Injection is used … Continue reading

Posted in Health Concerns, Pharmaceuticals, Product Recalls, Recalled Drugs | Tagged , , , , , , |

Lawsuits Increasing in the US and Canada with Risks of Xarelto Use

The blood thinner Xarelto (rivaroxaban) is a relatively new anticoagulant that has gained popularity through its convenience of use for the patient. Warfarin, also known as Coumadin, the established anticoagulant for the last 60 years, requires dietary restrictions and a … Continue reading

Posted in Health Concerns, Recalled Drugs |

Children’s Cough Syrups Recalled Because of Incorrect Dosing Cup

cough-Syrup

Perrigo Company of Dublin, Ireland, has initiated a voluntary recall of five batches of its children’s cough syrups because some packages contain an oral dosing cup with incorrect dose markings and children could receive an overdose of the medicine. The … Continue reading

Posted in Health Concerns, Pharmaceuticals, Recalled Drugs | Tagged , , , , |

Florida Pharmacy Recalls Multivitamin Capsules that May Cause Vitamin D Toxicity

The Food and Drug Administration (FDA) has alerted health care providers and patients to a voluntary recall of compounded multivitamin capsules containing high amounts of vitamin D3 (cholecalciferol), distributed nationwide by Glades Drugs in Pahokee, Florida. The FDA has received … Continue reading

Posted in Health Concerns, Pharmaceuticals, Product Recalls, Recalled Drugs |

Infant Death Triggers FDA Warning About Probiotic Dietary Supplements

The Food and Drug Administration (FDA) has formally warned healthcare providers about using dietary supplements containing live bacteria or yeast in patients with compromised immune systems. The warning explains that dietary supplements are not regulated in the United States as approved … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals, Product Recalls, Recalled Drugs |

Sun Pharmaceutical’s Effexor Recalled for the Second Time This Year

Sun Pharmaceutical Industries Ltd. has recalled 68,000 bottles of the antidepressant Effexor (venlafaxine), in the second recall of the drug this year, the Food and Drug Administration (FDA) said. In both instances, the recalled drug was manufactured at the Indian … Continue reading

Posted in Defective Products, Pharmaceuticals, Product Recalls, Recalled Drugs |

FDA: All Non-Expired Sterile Unique Pharmaceuticals’ Drugs Recalled

The U.S. Food and Drug Administration (FDA) advised that it is alerting health care professionals and consumers regarding a recall of all non-expired drug products meant for sterile use and sold and distributed by Unique Pharmaceuticals Ltd., located in Temple, … Continue reading

Posted in Pharmaceuticals, Product Recalls, Recalled Drugs |

FDA Announces Recall of Generic Versions of Heart Drug Toprol XL

Just a few months after one generic version of a popular extended-release blood pressure medication was recalled, a lot of metoprolol succinate from another manufacturer was recalled for the same reason:  the drug did not dissolve properly. The recalled drugs, … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals, Product Recalls, Recalled Drugs |

Indian Drugmaker Sun Pharma Recalls 400,000 Bottles of Two Drugs

Sun Pharma, India’s largest drugmaker, has announced the recall of almost 400,000 bottles of anti-depressant and antihistamine medications in the U.S. because the pills failed to dissolve properly. About 128,000 bottles of Sun Pharma’s antihistamine cetirizine, known by the brand … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals, Product Recalls, Recalled Drugs |

© 2005-2020 Parker Waichman LLP ®. All Rights Reserved.